Cargando…

OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients

Detalles Bibliográficos
Autores principales: López Jiménez, C., Blanco Abad, C., Catoya Villa, J.L., Gutiérrez Ortiz de la Tabla, A., Juliao Caamaño, D.S., Ortega Morán, L., Martín Jiménez, M., Muñoz Martín, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057539/
http://dx.doi.org/10.1016/S0049-3848(21)00144-4
_version_ 1783680859011809280
author López Jiménez, C.
Blanco Abad, C.
Catoya Villa, J.L.
Gutiérrez Ortiz de la Tabla, A.
Juliao Caamaño, D.S.
Ortega Morán, L.
Martín Jiménez, M.
Muñoz Martín, A.
author_facet López Jiménez, C.
Blanco Abad, C.
Catoya Villa, J.L.
Gutiérrez Ortiz de la Tabla, A.
Juliao Caamaño, D.S.
Ortega Morán, L.
Martín Jiménez, M.
Muñoz Martín, A.
author_sort López Jiménez, C.
collection PubMed
description
format Online
Article
Text
id pubmed-8057539
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80575392021-04-21 OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients López Jiménez, C. Blanco Abad, C. Catoya Villa, J.L. Gutiérrez Ortiz de la Tabla, A. Juliao Caamaño, D.S. Ortega Morán, L. Martín Jiménez, M. Muñoz Martín, A. Thromb Res Oral Communications Elsevier Ltd. 2021-04 2021-04-20 /pmc/articles/PMC8057539/ http://dx.doi.org/10.1016/S0049-3848(21)00144-4 Text en Copyright © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Oral Communications
López Jiménez, C.
Blanco Abad, C.
Catoya Villa, J.L.
Gutiérrez Ortiz de la Tabla, A.
Juliao Caamaño, D.S.
Ortega Morán, L.
Martín Jiménez, M.
Muñoz Martín, A.
OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
title OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
title_full OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
title_fullStr OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
title_full_unstemmed OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
title_short OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
title_sort oc-02 khorana risk score at diagnosis of sars-cov-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
topic Oral Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057539/
http://dx.doi.org/10.1016/S0049-3848(21)00144-4
work_keys_str_mv AT lopezjimenezc oc02khoranariskscoreatdiagnosisofsarscov2infectionasapredictingtoolforvenousthromboembolicdiseasedevelopmentandoverallmortalityincancerpatients
AT blancoabadc oc02khoranariskscoreatdiagnosisofsarscov2infectionasapredictingtoolforvenousthromboembolicdiseasedevelopmentandoverallmortalityincancerpatients
AT catoyavillajl oc02khoranariskscoreatdiagnosisofsarscov2infectionasapredictingtoolforvenousthromboembolicdiseasedevelopmentandoverallmortalityincancerpatients
AT gutierrezortizdelatablaa oc02khoranariskscoreatdiagnosisofsarscov2infectionasapredictingtoolforvenousthromboembolicdiseasedevelopmentandoverallmortalityincancerpatients
AT juliaocaamanods oc02khoranariskscoreatdiagnosisofsarscov2infectionasapredictingtoolforvenousthromboembolicdiseasedevelopmentandoverallmortalityincancerpatients
AT ortegamoranl oc02khoranariskscoreatdiagnosisofsarscov2infectionasapredictingtoolforvenousthromboembolicdiseasedevelopmentandoverallmortalityincancerpatients
AT martinjimenezm oc02khoranariskscoreatdiagnosisofsarscov2infectionasapredictingtoolforvenousthromboembolicdiseasedevelopmentandoverallmortalityincancerpatients
AT munozmartina oc02khoranariskscoreatdiagnosisofsarscov2infectionasapredictingtoolforvenousthromboembolicdiseasedevelopmentandoverallmortalityincancerpatients